Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Johnson & Johnson (JNJ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow J&J's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
144.42 -3.17    -2.15%
- Closed. Currency in USD ( Disclaimer )
After Hours
144.51
+0.09
+0.06%
- Real-time Data
  • Volume: 12,109,030
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 143.39 - 146.25
Type:  Equity
Market:  United States
J&J 144.42 -3.17 -2.15%

JNJ Income Statement & Profits

 
Assess the Johnson & Johnson income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
01/10
2023
02/07
2023
02/04
Total Revenue 21395 21351 25530 24746
Revenue 21395 21351 25530 24746
Other Revenue, Total - - - -
Cost of Revenue, Total 6715 6380 8012 8195
Gross Profit 14680 14971 17518 16551
Total Operating Expenses 16665 14930 18148 17545
Selling/General/Admin. Expenses, Total 5470 5103 6307 5787
Research & Development 4480 3447 3829 3563
Depreciation / Amortization -2240 - 734 680
Interest Expense (Income) - Net Operating -151 -192 -346 -215
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 2391 192 -388 -465
Operating Income 4730 6421 7382 7201
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets 1337 -1000 1 -76
Other, Net -1433 2204 620 8014
Net Income Before Taxes 4826 5217 6762 -737
Provision for Income Taxes 694 908 1618 -669
Net Income After Taxes 4132 4309 5144 -68
Minority Interest - - 1260 -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 4132 4309 5144 -68
Total Extraordinary Items -83 21719 - -
Net Income 4049 26028 5144 -68
Total Adjustments to Net Income 83 -21719 - -
Income Available to Common Excluding Extraordinary Items 4132 4309 5144 -68
Dilution Adjustment -75.08 21719.01 -2.37 10.16
Diluted Net Income 4124.08 4308.99 5146.37 -78.16
Diluted Weighted Average Shares 2766.67 2549.7 2625.7 2605.5
Diluted EPS Excluding Extraordinary Items 1.49 1.69 1.96 -0.03
DPS - Common Stock Primary Issue 1.19 1.19 1.19 1.13
Diluted Normalized EPS 1.07 1.64 1.78 1.8
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

JNJ Price Commentary

Write your thoughts about Johnson & Johnson
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Andre Van Laer
Andre Van Laer Aug 25, 2023 20:07
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Kenvur buyers return to jnj? Double discount/double dip...? LOL?
Nik Daniel
Nik Daniel Feb 18, 2023 7:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Niceee movement
Lee Baldwin
Lee Baldwin Aug 24, 2022 15:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Interest rates?
ifigeneia ifigeneia
ifigeneia ifigeneia Oct 15, 2021 16:00
Saved. See Saved Items.
This comment has already been saved in your Saved Items
FDA approved finally. Few minutes ago!!!!
Lee Baldwin
Lee Baldwin Oct 15, 2021 16:00
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What?
Lukas Bednall
Lukas Bednall Sep 22, 2021 19:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Invested in J&J a couples years back and have closely followed the pharmaceutical industry. Found a company by the name of SpectrumX which has an IPO set for November. SpectrumX are leaders in patented shielded HOCL formulations that have numerous applications in medical/pharma fields. They have also undergone 2 clinical trails for Covid-19 treatment (apparently not factored into the company valuation.) To me this company seems to be on track for high growth after the IPO, however I may be getting lost in the hype. Would love to hear people's thoughts on the stock as I am keen to invest early.
ifigeneia ifigeneia
ifigeneia ifigeneia Sep 22, 2021 19:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
To entry in Spectrum or not? What do you think?
Adam Whipps
Adam Whipps Sep 22, 2021 19:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Checking it out looks like a good punt
Oc Masai
Oc Masai Apr 24, 2021 11:07
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good job JNJ. move forward bullish
Lee Baldwin
Lee Baldwin Dec 29, 2020 15:31
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Stock split???
Sinisa Galesic
Sinisa Galesic Dec 22, 2020 23:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Where we go next?
Paul Strong
Paul Strong Dec 22, 2020 23:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
AMC! But ultimately it’s your decision.
Lee Baldwin
Lee Baldwin Oct 29, 2020 16:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good buy. 0at this price
AdrianQ Khew
AdrianQ Khew Jul 23, 2019 11:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
JNJ is going to Make a strong come back tonight!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email